ISSFAL 2006

the 7th in the series of International Congresses,was held in Cairns, Queensland,Australia, from July 23rd until July 28th 2006.

Outline Programme

The primary programme of this Congress took place over 4 days, Monday and Tuesday July 24th and 25th, and Thursday and Friday July 27th and 28th. Each day consisted of opening and closing plenary sessions, and in between were four concurrent sessions in the morning, and a further four in the afternoon. Two poster display sessions were used, session A being on display Monday and Tuesday, and session B being on display Thursday and Friday. This archive is set out with the outline programme on this page, which can be used to access the detailed programme for each day; (click on the day to go to the detailed programme for that day, or to go directly to any particular session); the detailed programme pages list the titles of each of the plenary and concurrent session papers presented that day, with underscored links that can be used to access the summary or abstract directly. The detailed programme pages for Tuesday 25th and Thursday 27th provide a listing of the poster titles for session A and session B respectively, with underscored links to take you to a summary of any poster.

*********************************************************************

Sunday July 23rd 2006: Aboriginal Welcome to Cairns

Official Opening of the Congress
Michel Lagarde, President of ISSFAL

The Great Debate: High linoleic acid diets are bad for your health

(sponsored by Columbus Paradigm Institute)

**********************************************************************

Monday 24th July 2006 Click on this link to go to the Monday page, from where abstracts can be accessed.

Plenary Session 1:Controversies and Consensus in Cardiovascular Disease

N-3 fatty acids, mortality and coronary heart disease: evidence from randomised controlled trials. Rudolph Riemersma, Scotland

Antioxidants – do they do anything? Kevin Croft, Australia

What are the health effects of trans fat and CLA? All bad for industrially produced trans fat, and both good and bad for CLA. Penny Kris-Etherton, USA .

Concurrent Session 1- Cancer;

Concurrent Session 2 - Brain Composition & Function 1;

Concurrent Session 3- CVD Interventions;

Concurrent Session 4- Novel Lipids;

Concurrent Session 5- Diet Status;

Concurrent Session 6 - Brain Composition & Function 2;

Concurrent Session 7- Dietary PUFA and Cholesterol;

Concurrent Session 8- Lipids in Parenteral and Enteral Nutrition.

Plenary Session 2: Brain and Vision

Docosahexaenoic acid signaling in Ageing, Stroke and Alzheimers Disease. Nicolas Bazan, USA.

Selected short communications

Dietary omega-3 fatty acids decrease intraocular pressure with age. Nguyen C.

Dietary omega-3 long-chain polyunsaturated fatty acid intake is associated with visual acuity performance in the age-related eye disease study (AREDS). San Giovanni J.

Genomic studies on the brain of transgenic mouse capable of converting n-6 to n-3 fatty acids. Puskas L.

Poster Session A (Click on this link to go to a list of posters presented in the first poster session. A summary of the poster content can then be accessed by clicking on the individual poster links).

Tuesday July 25th 2006

Bioactive lipids and their nutrient interactions. Sheila Innis, Canada .

Prenatal fatty acid exposure and early immune development Susan Prescott, Australia .

Systematic reviews and large scale randomised controlled trials: we’ve come a long way baby! Maria Makrides, Australia.

Concurrent Session 9- Fatty Acid Metabolism;

Concurrent Session 10- Pregnancy and Lactation ;

Concurrent Session 11- Vascular Function;

Concurrent Session 12- Methods;

Concurrent Session 13- PUFA Metabolism 2;

Concurrent Session 14- Maternal Status;

Concurrent Session 15- Cardiac Compostion;

Concurrent Session 16- Brain and Vision.

Plenary Session 4: Controversies and consensus in dietary fats.

Omega-3 pufa and the metabolic syndrome. Yolanda Lombardo, Argentina.

Dietary fats and longevity. Harumi Okuyama, Japan .

A tale of omega-3: from fat to fat-1. Jing Kang, USA.

Thursday July 27th 2006 (Wednesday 26th was a rest day)

Plenary Session 5:Controversies and consensus in eicosanoids .

Lipid mediators in inflammatory resolution;Derek Gilroy, UK.

Cox-2 inhibitors: biology, ethics, law. Michael James, Australia

Concurrent Session 17- Eicosanoids;

Concurrent Session 18- Perinatal Interventions and Developmental Outcomes;

Concurrent Session 19- Plasma Lipids;

Concurrent Session 20- Ageing and the Brain;

Concurrent Session 21-Immunology;

Concurrent Session 22- Lipids and Child Health;

Concurrent Session 23- Diabetes;

Concurrent Session 24- Mental Health.

Plenary Session 6: Selected short communications

Genetic variants of fatty acid desaturases 1 and 2 are associated with the fatty acid composition of human serum phospholipids. Schaeffer L.

Cell based multi-well assays for detection of substrate accumulation and oxidation. Rustan A.

A 2d quantitative lipidomic approach to lipid analysis in human skeletal muscle: influence of glycogen and exercise. Ekroos K.

Isolation and characterization of polyunsaturated fatty acid producing thraustochytrium species: screening of strains and optimization of omega-3 production. Burja A.

Lcpufa status of preterm infants: a randomised trial comparing two doses of docosahexaenoic acid.
Smithers L.

Relationships between erythrocyte, plasma and myocardial n-3 fatty acids in humans .Metcalf R.

High throughput fatty acid analysis . Salem N.Jr.

Poster Session B (Click on this link to go to a list of posters presented. A summary of the posters content can then be accessed by clicking on the individual poster titles).

Friday July 28th 2006

Plenary Session 7:Controversies and consensus in metabolism

Neurotrophic effects of docosahexaenoic acid: mechanistic investigation .Hee-Yong Kim, USA

Membrane fatty acids as pacemakers of animal metabolism . Tony Hulbert, Australia

What are the normal rates of human brain metabolism of arachidonic and docosahexaenoic acids, and what may happen when their metabolic balance is altered by dietary n-3 pufa deprivation? Stanley Rapoport, USA.

Concurrent Session 25- Obesity and Metabolic Dysfunction;

Concurrent Session 26- Child Cognition;

Concurrent Session 27- Inflammation 1;

Concurrent Session 28 - Lipidomics 1;

Concurrent Session 29 -Bone Health;

Concurrent Session 30 -Maternal-Infant Round Table Discussion;

Concurrent Session 31 - Inflammation 2;

Concurrent Session 32 - Lipidomics 2.

Discussion group 1: Fish as a source of DHA ; Chairs: Joyce Nettleton & Les Cleland

Discussion group 2: Margarines; Chairs: Andrew Sinclair & Philip Calder

Discussion group 3: Arachidonic Acid; Chairs: Robert Gibson & Tom Brenna

Discussion group 4: Systematic Reviews; Chairs: Maria Makrides & John Paul Sangiovanni

Close of Conference.